Obesity

Novo Nordisk A/S Almost a third of adults taking Wegovy® pill (oral semaglutide 25 mg) were early responders…

A new systematic review and meta-analysis of studies presented at this year’s European Congress on Obesity in Istanbul,…

Here’s something to chew on. Brains require nutrients from a variety of foods like fruits, vegetables, fatty fish,…

Coaches and athletes across eight countries say sports clubs could become powerful community health hubs, but only if…

A major real-world study links GLP-1 receptor agonists to improved survival and lower recurrence risk in women with…

Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though…

May 12, 2026 At a Glance People with alcohol use disorder and obesity drank less when treated with…

After 14 years of research and 22,000 survey responses, polycystic ovary syndrome (PCOS) has officially been renamed polyendocrine…

Type 2 diabetes affects millions of people worldwide and now a new international study, jointly led by Adelaide…

In the Ozempic era, not all pounds lost are met with praise. New research suggests that people may…

Researchers analyzing nearly 10,000 U.K. news articles found that Type 1 diabetes is often portrayed through medical and…

Glucagon-like peptide-1 (GLP-1) medications are drugs used to treat type 2 diabetes and support weight loss. They mimic…

Wegovy® pill delivered 21.6% weight loss in early responders and doubled mobility improvement, according to new Novo Nordisk data at ECO2026